Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Diabetic Retinopathy

Trial Information

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Official Title: Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema.

Summary

The purpose of this study is to test the efficacy of an 0.7 mg intravitreal dexamethasone implant (Ozurdex®) on macular leakage and visual acuity for patients with recalcitrant diabetic macular edema.

Phase: Phase 2

Sponsor: Retina Macula Institute

Overall Contacts:

Gina Kim, B.S
310-944-9393

Locations (1)

Country State City Zip Facility and Contact
United States California Torrance 90503 Retina Macula Institute
Gina Kim, B.S
310-944-9393
gina.kim@retinamaculainstitute.com

Ron P Gallemore, M.D, Ph.D
Principal Investigator

Mehran Taban, M.D
Sub-Investigator

Ray Oyakawa, M.D
Sub-Investigator

Behnam Sharareh, B.S
Sub-Investigator

NCT ID:NCT01571232

Date Last Changed: January 13, 2013